#800 The effect of canagliflozin dose on cardiovascular and renal outcomes in patients with type 2 diabetes and high cardiovascular risk
Sign Up to like & getrecommendations! Published in 2025 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfaf116.037
Abstract: Sodium-glucose co-transporter-2 (SGLT-2) inhibitors have revolutionized the management of chronic kidney disease (CKD). As shown in large randomized clinical trials, they reduce the incidence of atherosclerotic cardiovascular disease and heart failure and they delay CKD… read more here.
Keywords: canagliflozin; effect; type diabetes; high cardiovascular ... See more keywords
Overtreatment of older people with type 2 diabetes—a high impact frequent occurrence in need of a new definition
Sign Up to like & getrecommendations! Published in 2022 at "Diabetic Medicine"
DOI: 10.1111/dme.14994
Abstract: Diabetes overtreatment is a frequent and major issue in older people with type 2 diabetes but its definition is often inconsistent and may be misleading. This critical review has aimed at examining the definitions of… read more here.
Keywords: definition; people type; diabetes high; overtreatment older ... See more keywords